Does Cabergoline prevent weight regain in people with obesity?

Phase 4

Completed

• Conditions: Obesity; Metabolic and Endocrine - Metabolic disorders; Diet and Nutrition - Obesity

• Registration Number: ACTRN12612000069853
• Lead Sponsor: Health Research Council

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-01-13
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

BMI>30 (lean participants for substudy - BMI <25)
Male or female
20-65 years
pre-menopausal women must be using apropriate contraception

Exclusion Criteria

BMI <30 (lean participants for substudy - BMI >25)
Diabetes
Malignance
Cardiac disease
vascular disease
uncontrolled hypertension
psychiatric disease
other significant medical condition
women with child-bearing potential (not on appropriate contraception)
Participants using medication that could interact with cabergoline

Study & Design

• Study Type: Interventional
• Study Design: Not specified